Testosterone Cypionate

Category
hormone
Half-Life (t½)
IM: 8d
Formula
C27H40O3
Molecular Weight
412.61 g/mol
PubChem CID
441404
Aliases
test cyp

Pharmacological Mechanism

Androgen receptor agonist; aromatized to estradiol.

Half-Life & Elimination Curve (IM: 8d)

100%50%25%12.5%0%0h0×t½8d1×t½16d2×t½24d3×t½32d4×t½40d5×t½0×t½ (0h): 100% remaining1×t½ (8d): 50% remaining2×t½ (16d): 25% remaining3×t½ (24d): 12.5% remaining4×t½ (32d): 6.3% remaining5×t½ (40d): 3.1% remaining
Plasma (IM)t½ Decay (8d)Effect Site (ke0)
  • 0×t½0h100%
  • 1×t½8d50%
  • 2×t½16d25%
  • 3×t½24d12.5%
  • 4×t½32d6.3%
  • 5×t½40d3.1%
Elimination t½8d (IM)
Rate Constant (ke)0.00361 h⁻¹
Time to Peak (Tmax)66.1h
Clearance (CL)0.181 L/h
97% Washout (5×t½)40d

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Notes

Prescription only. TRT context. IM depot models slow first-order absorption (ka ≈ 0.04/hr) into a two-compartment system: distribution α ≈ 0.05/hr (~14h), terminal β ≈ 0.0036/hr (~190h half-life). Replaces the v0.5 1-comp slow-ka approximation. AR receptor-occupancy row removed (2026-06-28 audit): its ~1 nM value was free-testosterone’s affinity cited to a guideline with no verbatim Ki; steroid AR Kd/Ki have no abstract-verbatim source per AUTHORING_GAPS.

Chemical Structure & Identifiers

References